124 related articles for article (PubMed ID: 33368959)
1. Serial Quantiferon-TB Gold test results in 279 patients with psoriasis receiving biologic therapy.
Akdogan N; Dogan S; Gulseren D; Yalici-Armagan B; Ersoy-Evans S; Elcin G; Karaduman A; Atakan N
Dermatol Ther; 2021 Jan; 34(1):e14699. PubMed ID: 33368959
[TBL] [Abstract][Full Text] [Related]
2. The seroconversion rate of QuantiFERON-TB Gold In-Tube test in psoriatic patients receiving secukinumab and ixekizumab, the anti-interleukin-17A monoclonal antibodies.
Wu CY; Chiu HY; Tsai TF
PLoS One; 2019; 14(12):e0225112. PubMed ID: 31881026
[TBL] [Abstract][Full Text] [Related]
3. Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab.
Hsiao CY; Chiu HY; Wang TS; Tsai TF
PLoS One; 2017; 12(9):e0184178. PubMed ID: 28886099
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.
Sauzullo I; Mengoni F; Marocco R; Potenza C; Skroza N; Tieghi T; Lichtner M; Vullo V; Mastroianni CM
Br J Dermatol; 2013 Nov; 169(5):1133-40. PubMed ID: 23909256
[TBL] [Abstract][Full Text] [Related]
5. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of serial QuantiFERON-TB Gold in tube test results and tuberculosis infection status in patients with psoriasis receiving anti-IL-17 treatment (secukinumab and ixekizumab): Real-world data from a tuberculosis-endemic country.
Erbağcı E; Koç Yıldırım S; Hapa FA
Australas J Dermatol; 2024 Jul; ():. PubMed ID: 38946637
[TBL] [Abstract][Full Text] [Related]
7. QuantiFERON TB-gold conversion rate among psoriasis patients under biologics: a 9-year retrospective study.
Megna M; Ferrillo M; Ruggiero A; Cinelli E; Gallo L; Fabbrocini G
Int J Dermatol; 2021 Mar; 60(3):352-357. PubMed ID: 32989759
[TBL] [Abstract][Full Text] [Related]
8. Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy.
Drago L; Nicola L; Signori V; Palazzi E; Garutti C; Spadino S; Altomare G
Dermatol Ther (Heidelb); 2013 Jun; 3(1):73-81. PubMed ID: 23888257
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers.
Saraceno R; Specchio F; Chiricozzi A; Sarmati L; Amicosante M; Chimenti MS; Chimenti S
Expert Opin Biol Ther; 2014 Feb; 14(2):151-6. PubMed ID: 24303977
[TBL] [Abstract][Full Text] [Related]
10. Is chemoprophylaxis necessary for all latent tuberculosis infection patients receiving IL-17 inhibitors? A cohort study.
Shu D; Zhang Z; Zhou EY; Ma X; Zhao Y
Dermatol Ther; 2020 Nov; 33(6):e14512. PubMed ID: 33166023
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis after liver transplantation in a large center in New York City: QuantiFERON
Hand J; Sigel K; Huprikar S; Hamula C; Rana M
Transpl Infect Dis; 2018 Apr; 20(2):e12845. PubMed ID: 29359834
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.
Dyrhol-Riise AM; Gran G; Wentzel-Larsen T; Blomberg B; Haanshuus CG; Mørkve O
BMC Infect Dis; 2010 Mar; 10():57. PubMed ID: 20210999
[TBL] [Abstract][Full Text] [Related]
13. QuantiFERON-TB Gold Plus Is a More Sensitive Screening Tool than QuantiFERON-TB Gold In-Tube for Latent Tuberculosis Infection among Older Adults in Long-Term Care Facilities.
Chien JY; Chiang HT; Lu MC; Ko WC; Yu CJ; Chen YH; Hsueh PR
J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29793966
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
[TBL] [Abstract][Full Text] [Related]
15. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana.
Mensah GI; Sowah SA; Yeboah NY; Addo KK; Jackson-Sillah D
Int J Mycobacteriol; 2017; 6(1):27-33. PubMed ID: 28317801
[TBL] [Abstract][Full Text] [Related]
16. QuantiFERON®-TB Gold In-Tube test can be used for screening latent tuberculosis before biological treatment in a Bacille Calmette-Guérin (BCG)-vaccinated country: the HUR-BIO single-center real-life results.
Seyhoglu E; Uyaroğlu OA; Erden A; Kilic L; Karadag O; Akdogan A; Bilgen SA; Ertenli I; Kiraz S; Kalyoncu U
Clin Rheumatol; 2021 May; 40(5):2027-2035. PubMed ID: 33057917
[TBL] [Abstract][Full Text] [Related]
17. QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment.
Lee H; Park HY; Jeon K; Jeong BH; Hwang JW; Lee J; Cha HS; Koh EM; Kang ES; Koh WJ
PLoS One; 2015; 10(3):e0119260. PubMed ID: 25746854
[TBL] [Abstract][Full Text] [Related]
18. No seroconversion in a retrospective study analyzing QuantiFERON TB-gold testing in pediatric psoriasis and hidradenitis suppurativa patients taking biologic therapy at an academic center in New York City.
Katsiaunis A; Conway J; Lipner SR
Pediatr Dermatol; 2024 Feb; ():. PubMed ID: 38413181
[TBL] [Abstract][Full Text] [Related]
19. Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study.
Garcovich S; Ruggeri A; D'Agostino M; Ardito F; De Simone C; Delogu G; Fadda G
J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1572-6. PubMed ID: 21923840
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
